title: Is Leishmania infantum zymodeme MON-253 involved in an outbreak among intravenous drug users?
authors.affiliation: WHO Collaborating Centre on Leishmaniasis, Research Unit in Tropical Medicine and International Health (FIS-ISCIII), Madrid, Spain. cchichar@isciii.es
authors.forename: C
authors.initials: C
authors.lastname: Chicharro
authors.forename: G
authors.initials: G
authors.lastname: Sirera
authors.forename: M
authors.initials: M
authors.lastname: Ares
authors.forename: A
authors.initials: A
authors.lastname: Sans
authors.forename: S
authors.initials: S
authors.lastname: Videla
authors.forename: J
authors.initials: J
authors.lastname: Alvar
mesh_terms: D000818:Animals; D004196:Disease Outbreaks; D006801:Humans; D018314:Leishmania infantum / Q000302:isolation & purification*; D007898:Leishmaniasis, Visceral / Q000453:epidemiology* / Q000469:parasitology; D013030:Spain / Q000453:epidemiology; D015819:Substance Abuse, Intravenous / Q000453:epidemiology* / Q000469:parasitology